NGAL Antibodies
Target-specific antibody reagent for development, optimization and analytical evaluation of assays involving NGAL. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury.
Product Type
Antibodies & Antigens
Sub-Category
Analyte Antibodies
Platform
LFA, TIA
Application
REN
Overview
Target-specific antibody reagent for development, optimization and analytical evaluation of assays involving NGAL. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury.
Target-specific antibody reagent for development, optimization and analytical evaluation of assays involving NGAL. Kidney-injury research target that can rise earlier than creatinine in acute kidney injury. NGAL can rise early in plasma or urine after kidney injury and has been extensively studied as an AKI biomarker. Reference populations and decision values remain method and context dependent.
Professional Context
NGAL can rise early in plasma or urine after kidney injury and has been extensively studied as an AKI biomarker. Reference populations and decision values remain method and context dependent.
Technical Specifications
Antibody Information
| Parameter | Specification |
|---|---|
| Target | NGAL |
| Technology Platform | Lateral Flow & Colloidal Gold |
| Application Tags | REN |
| Storage | 2~8℃ |
| Shelf Life | 2年 |
| Sample Pack | 1mg; 2mg |
Target
NGAL
Technology Platform
Lateral Flow & Colloidal Gold
Application Tags
REN
Storage
2~8℃
Shelf Life
2年
Sample Pack
1mg; 2mg
Technical Resources
Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.
Need to confirm the right product or material for your project?
Our technical team can assist with product selection, provide samples, and support your IVD development project.